Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Assets (2010 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Assets came in at $9.4 million in Q2 2026, up 31.98% year-over-year from $7.1 million in Q2 2025, and up 45.6% quarter-over-quarter from $6.4 million in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Assets (2010 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Assets for 17 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Assets rose 31.98% year-over-year to $9.4 million in Q2 2026; TTM through Jun 2026 was $9.4 million, a 31.98% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 17.1% from the prior year.
  • Assets was $9.4 million for Q2 2026 at Creative Medical Technology Holdings, up from $6.4 million in the prior quarter.
  • Over five years, Assets peaked at $23.4 million in Q2 2022 and troughed at $5.9 million in Q3 2025.
  • A 5-year average of $11.3 million and a median of $9.5 million in 2024 frame the typical range for Assets.
  • Across the five-year window, Assets surged 3100.04% in 2022 and slumped 44.96% in 2024, its largest moves.
  • Over 5 years, Assets stood at $19.2 million in 2022, then plunged by 44.15% to $10.7 million in 2023, then plunged by 37.76% to $6.7 million in 2024, then advanced by 17.1% to $7.8 million in 2025, then climbed by 20.08% to $9.4 million in 2026.
  • The last three Assets figures came in at $9.4 million (Q2 2026), $6.4 million (Q1 2026), and $7.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 1.50 Bn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - 2.65 Bn
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 915.53 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 1.75 Bn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 985.10 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn - 1.39 Bn
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 170.30 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 3.19 Bn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 502.87 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 9.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.38 Mn
Mar 31, 2026 6.44 Mn
Dec 31, 2025 7.81 Mn
Sep 30, 2025 5.85 Mn
Jun 30, 2025 7.11 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 6.67 Mn
Sep 30, 2024 6.89 Mn
Jun 30, 2024 7.99 Mn
Mar 31, 2024 9.62 Mn
Dec 31, 2023 10.72 Mn
Sep 30, 2023 12.51 Mn
Jun 30, 2023 14.13 Mn
Mar 31, 2023 15.23 Mn
Dec 31, 2022 19.19 Mn
Sep 30, 2022 22.47 Mn
Jun 30, 2022 23.43 Mn
Mar 31, 2022 9.73 Mn
Dec 31, 2021 11.27 Mn
Sep 30, 2021 3.13 Mn